top of page

Free On-Demand Webinar:
👉 Strategic CMC for Biotech & Pharma: How to Avoid Costly FDA Delays

CMC Drug Development Tips

ICH M4Q(R2) - a dual overhaul of Modules 2 and 3

Nexus CMC Advisors
ICH M4Q(R2) - a dual overhaul of Modules 2 and 3
ICH M4Q(R2) - a dual overhaul of Modules 2 and 3

ICH M4Q(R2) - a dual overhaul of Modules 2 and 3

00:52
Classifying CMC Changes During Clinical Development

Classifying CMC Changes During Clinical Development

00:54
Risk Assessments for Clinical-Stage CMC Changes

Risk Assessments for Clinical-Stage CMC Changes

00:47
Phase 2 and Phase 3 manufacturing changes

Phase 2 and Phase 3 manufacturing changes

00:44
Intro to CMC for Peptide Therapeutics
03:29
IND CMC Information
00:17
Phase Appropriate CMC Content
00:16
IND Common Pitfalls
00:16
Balancing Regulatory Requirements with Flexibility
00:16

© 2024-Present by Nexus CMC Advisors LLC.

bottom of page